2m 2m 2m 2m 2m 2m 2m
Lifeward (LFWD)
NASDAQ
$7.21-$0.47 (-6.12%)
Price as of Jun 03, 2026 4:32 PM EDT- $35.8MMarket Cap
- -48.80%1-Year Change
- Medical DevicesIndustry
Lifeward (LFWD)
$7.21-$0.47 (-6.12%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 22.0M -14.14% | 25.7M +85.24% | 13.9M +151.39% | 5.5M -7.63% | |
Cost of Revenue | 13.6M -22.02% | 17.4M +85.59% | 9.4M +160.70% | 3.6M +17.73% | |
Gross Profit | 8.4M +2.58% | 8.2M +84.50% | 4.5M +133.75% | 1.9M -34.38% | |
Sales and Marketing Expense | 13.9M -22.70% | 17.9M +28.93% | 13.9M +41.45% | 9.8M +40.74% | |
Research and Development Expense | -3.2M -29.75% | -4.6M +11.50% | -4.1M +2.90% | -4.0M +37.16% | |
Depreciation and Amortization Expense | 0 -100.00% | 3.3M +108.15% | 1.6M +696.04% | 202,000 -24.06% | |
Total Operating Expenses | 28.1M -25.19% | 37.6M +33.84% | 28.1M +33.60% | 21.0M +35.02% | |
Operating Profit | -19.7M -32.96% | -29.3M +24.29% | -23.6M +23.61% | -19.1M +50.94% | |
Interest Income | N/A N/A | 643,000 -52.51% | 1.4M N/A | N/A N/A | |
Interest Expense | -312,000 N/A | 0 N/A | N/A N/A | 0 +100.00% | |
Interest Income and Expense and Net | -312,000 -148.52% | 643,000 -52.51% | 1.4M N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | -312,000 N/A | 0 -100.00% | 11,000 N/A | N/A N/A | |
Income before Taxes | -20.0M -30.90% | -28.9M +30.50% | -22.1M +15.93% | -19.1M +51.10% | |
Income Taxes | -55,000 -227.91% | 43,000 +458.33% | -12,000 -102.57% | 467,000 +396.81% | |
Extraordinary Items | 2.8M -71.58% | 9.8M N/A | N/A N/A | N/A N/A | |
Net Income | -19.9M -31.19% | -28.9M +30.76% | -22.1M +13.10% | -19.6M +53.65% | |
Net Income from Continuing Operations Applicable to Common | -20.0M -30.90% | -28.9M +30.50% | -22.1M +15.93% | -19.1M +51.10% | |
Basic EPS and Net Income | -17.16 +415.32% | -3.33 +800.00% | -0.37 +19.35% | -0.31 +14.81% | |
Diluted EPS and Net Income | -17.16 +415.32% | -3.33 +800.00% | -0.37 +19.35% | -0.31 +14.81% | |
Basic Weighted Average Shares | 1.2M -86.65% | 8.7M -85.45% | 59.7M -4.26% | 62.4M +30.13% | |
Diluted Weighted Average Shares | 1.2M -86.65% | 8.7M -85.45% | 59.7M -4.26% | 62.4M +30.13% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.2M -67.85% | 6.7M -75.98% | 28.1M -58.64% | 67.9M -23.14% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.2M -67.85% | 6.7M -75.98% | 28.1M -58.64% | 67.9M -23.14% | |
Total Current Assets | 15.8M -25.77% | 21.3M -45.71% | 39.2M -45.91% | 72.5M -21.63% | |
Accumulated Depreciation | 7.3M +3.94% | 7.0M +10.93% | 6.3M +74.92% | 3.6M +5.90% | |
Property and Plant and Equipment and Net | 585,000 -32.53% | 867,000 -31.30% | 1.3M +543.88% | 196,000 -30.99% | |
Total Long-Term Assets | 7.1M -22.84% | 9.2M -61.65% | 24.0M +1,288.76% | 1.7M -22.57% | |
Total Assets | 500,000 -98.36% | 30.5M -51.75% | 63.2M -14.88% | 74.2M -21.65% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 2.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 12.0M +17.74% | 10.2M -13.31% | 11.8M +146.65% | 4.8M +18.42% | |
Total Long-Term Debt | 1.8M +400.00% | 362,000 -48.94% | 709,000 -32.54% | 1.1M -4.89% | |
Total Long-Term Liabilities | 2.5M +73.60% | 1.4M -71.09% | 4.9M +279.13% | 1.3M -3.01% | |
Total Liabilities | 14.5M +24.52% | 11.6M -30.24% | 16.7M +174.78% | 6.1M +13.12% | |
Retained Earnings | -284.7M +7.52% | -264.8M +12.27% | -235.9M +10.35% | -213.8M +10.08% | |
Total Stockholders Equity | 8.4M -55.39% | 18.8M -59.47% | 46.5M -31.77% | 68.2M -23.74% | |
Total Shares Outstanding | 1.5M -82.69% | 8.8M -85.35% | 60.1M +0.03% | 60.1M -3.82% | |
Cash Flow | |||||
Cash from Operating Activities | -16.8M -22.53% | -21.7M +5.09% | -20.7M +15.52% | -17.9M +55.99% | |
Capital Expenditures | 16,000 N/A | 0 -100.00% | 81,000 +224.00% | 25,000 -46.81% | |
Cash from Investing Activities | -16,000 N/A | 0 +100.00% | -18.1M +72,496.00% | -25,000 -46.81% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.2M N/A | 0 +100.00% | -992,000 -60.32% | -2.5M -103.14% | |
Financials Ratio | |||||
Gross Margin | 38.25% +19.48% | 32.02% -0.40% | 32.14% -7.02% | 34.57% -28.96% | |
Operating Margin | -89.29% -21.92% | -114.36% -32.90% | -170.43% -50.83% | -346.62% +63.41% | |
Return on Assets | -128.53% +108.01% | -61.79% +91.83% | -32.21% +39.07% | -23.16% +11.67% | |
Return on Equity | -146.12% +64.99% | -88.56% +129.43% | -38.60% +55.39% | -24.84% +8.41% | |
Revenue Growth | -14.14% -116.59% | 85.24% -43.70% | 151.39% +2,085.00% | -7.63% -121.30% | |
Current Ratio | 1.31 -36.95% | 2.08 -37.37% | 3.33 -78.07% | 15.16 -33.82% | |
Cash Ratio | 0.18 -72.69% | 0.66 -72.29% | 2.38 -83.23% | 14.20 -35.10% | |
Debt-to-Equity Ratio | 0.55 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 9.23 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow